• ARS Pharmaceuticals (NASDAQ:SPRY) Given Outperform Rating at William Blair

    Source: Buzz FX / 03 Mar 2025 10:16:16   America/New_York


    ARS Pharmaceuticals (NASDAQ:SPRY) Given Outperform Rating at William Blair Written by MarketBeat March 3, 2025 Share Link copied to clipboard. ARS Pharmaceuticals ( NASDAQ:SPRY - Get Free Report ) 's stock had its "outperform" rating reiter
    Read more...
Share on,